Pelthos Therapeutics Inc. - 8-K Filing
Pelthos Therapeutics enters into merger agreement to acquire Castle Creek Biosciences via two-step merger structure. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 3.02 Unregistered Sales of Equity Securities, 3.03 Material Modification to Rights of Security Holders)
Tickers: $PTHS